Skip to main content

Diffusion Pharmaceuticals Inc. Common Stock (DFFN)

About The Company

DFFN Stock Market Logo

Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company’s lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

Diffusion Pharmaceuticals Inc. (DFFN) Latest News

Company Contact & Address (DFFN)

Corporate Headquarters Phone Website
United States
+1 434 220-0718 Official DFFN Website

DFFN Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ DFFN

Jobs & Employment at Diffusion Pharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs & Employment at Diffusion Pharmaceuticals Inc. (DFFN)

Related & Similar Stock Symbols

RIV Stock Market Price & News


RiverNorth Opportunities Fund Inc. Common Stock

GS^J Stock Market Price & News


Goldman Sachs Group Inc Depositary Shs Repstg 1/1000…

MDLZ Stock Market Price & News


Mondelez International Inc. Class A Common Stock